GENTAUR Belgium BVBA BE0473327336 Voortstraat 49, 1910 Kampenhout BELGIUM Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc,Logistics 547 Yurok Circle, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, [email protected]
Suppliers:

US Biomax

Country : | Number of Products : | View all products

About this Supplier:

MNO961 35 types of normal human tissue array, 90 cases_96 cores
MNO961 35 types of normal human tissue array, 90 cases_96 cores; ihc H&E, IHC anti-Vimentin_Cytokeratin
MC804 Adamantinoma and hamartoma tissue array, 40 cases_80 cores
MC804 Adamantinoma and hamartoma tissue array, 40 cases_80 cores; ihc Anti-Actin confirmed
BC01081 Adenocarcinoma of stomach, colon and rectum high density tissue array, 556 cases_616 cores
BC01081 Adenocarcinoma of stomach, colon and rectum high density tissue array, 556 cases_616 cores; ihc Anti-EMA confirmed
SO2083 Adipose tissue disease spectrum (adipose tumor progression) tissue array, 104 cases_208 cores
SO2083 Adipose tissue disease spectrum (adipose tumor progression) tissue array, 104 cases_208 cores; ihc Anti-Actin confirmed
T433 Adrenal gland cancer test tissue array, with normal tissue, 2 serial sections, 6 cases_24 cores
T433 Adrenal gland cancer test tissue array, with normal tissue, 2 serial sections, 6 cases_24 cores; ihc Anti-Actin confirmed
AD2081 Adrenal gland disease spectrum (adrenal cancer progression) tissue array, 100 cases_200 cores
AD2081 Adrenal gland disease spectrum (adrenal cancer progression) tissue array, 100 cases_200 cores; ihc Anti-Actin confirmed
AG801 Adrenal tumor tissue array, 80 cases_80 cores
AG801 Adrenal tumor tissue array, 80 cases_80 cores; ihc Anti-Actin confirmed
BR8013 Advanced breast cancer and normal tissue array, with stage, TNM and pathology grade info, 80 cases_80 cores
BR8013 Advanced breast cancer and normal tissue array, with stage, TNM and pathology grade info, 80 cases_80 cores; ihc Anti-Actin confirmed
CO807 Advanced colon cancer tissue array, with stage and grade info, 80 cases_80 cores
CO807 Advanced colon cancer tissue array, with stage and grade info, 80 cases_80 cores; ihc Anti-Actin confirmed
CO1922 Advanced colon tumor tissue array, including TNM, clinical stage and pathology grade, 96 cases_192 cores
CO1922 Advanced colon tumor tissue array, including TNM, clinical stage and pathology grade, 96 cases_192 cores; ihc Anti-Actin confirmed
KD806 Advanced kidney cancer tissue array, with stage and grade info, 80 cases_80 cores
KD806 Advanced kidney cancer tissue array, with stage and grade info, 80 cases_80 cores; ihc Anti-Actin confirmed
LC816 Advanced lung cancer and normal tissue array, with stage TNM and grade info, 80 cases_80 cores
LC816 Advanced lung cancer and normal tissue array, with stage TNM and grade info, 80 cases_80 cores; ihc Anti-Actin confirmed
SK243 Age grouped female skin tissue array, 12 cases_24 cores, replaced by SK244
SK243 Age grouped female skin tissue array, 12 cases_24 cores, replaced by SK244; ihc Anti-Actin confirmed
SK244 Age grouped female skin tissue array, 12 cases_24 cores, replacing SK243
SK244 Age grouped female skin tissue array, 12 cases_24 cores, replacing SK243
SK244 Age grouped female skin tissue array, 12 cases_24 cores, replacing SK243; ihc Anti-Actin confirmed
MNO341 Antibody cross-reactivity testing tissue array, 33 cases_34 cores; ihc H&E, IHC anti-Vimentin_Cytokeratin
MNO341 Antibody cross_reactivity testing tissue array, 33 cases_34 cores
T413 Appendix cancer test tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 6 cases_24 cores
T413 Appendix cancer test tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 6 cases_24 cores; ihc Anti-Actin confirmed
GL481 Astrocytoma and glioblastoma tissue array with unmatched normal adjacent tissues, 48 cases_48 cores; ihc Anti-Actin confirmed
BL803 Bladder cancer and normal tissue array with TNM and grade data, 40 cases_80 cores
BL803 Bladder cancer and normal tissue array with TNM and grade data, 40 cases_80 cores; ihc Anti-Actin confirmed
BL1002 Bladder cancer and normal tissue array, including TNM and pathology grade, 50 cases_100 cores
BL1002 Bladder cancer and normal tissue array, including TNM and pathology grade, 50 cases_100 cores; ihc Anti-Actin confirmed
BL2081 Bladder cancer high density tissue array, 203 cases_208 cores
BL2081 Bladder cancer high density tissue array, 203 cases_208 cores; ihc Anti-Actin confirmed
BLC1501 Bladder cancer mid-density tissue array, 75 cases_150 cores; ihc H&E, IHC anti-Cytokeratin
BLC1501 Bladder cancer mid_density tissue array, 75 cases_150 cores
T124 Bladder cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases_24 cores, replacing T122; ihc Anti-Actin confirmed
T123 Bladder cancer test tissue array, with normal bladder tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases_24 cores
T123 Bladder cancer test tissue array, with normal bladder tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases_24 cores; ihc Anti-Actin confirmed
T121 Bladder cancer test tissue array, with normal bladder tissue as control, including TNM, clinical stage and pathology grade, 6 cases_24 cores
T121 Bladder cancer test tissue array, with normal bladder tissue as control, including TNM, clinical stage and pathology grade, 6 cases_24 cores; ihc Anti-Actin confirmed
T122 Bladder cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases_24 cores
T122 Bladder cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases_24 cores, replaced by T124; ihc Anti-Actin confirmed
BL1001 Bladder cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases_100 cores
BL1001 Bladder cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases_100 cores; ihc Anti-Actin confirmed
BL244 Bladder cancer tissue array with matched adjacent bladder tissue, including TNM, clinical stage and pathology grade, 12 cases_24 cores; ihc Anti-Actin confirmed
BL802 Bladder cancer tissue array with normal tissue, 80 cases_80 cores, replacing BC12012
BL802 Bladder cancer tissue array with normal tissue, 80 cases_80 cores, replacing BC12012; ihc Anti-Actin confirmed
BL243 Bladder cancer tissue array with normal tissues from autopsy, 12 cases_24 cores with stage and grade data
BL243 Bladder cancer tissue array with normal tissues from autopsy, 12 cases_24 cores with stage and grade data; ihc Anti-Actin confirmed
BL241 Bladder cancer tissue array with self-matching normal adjacent tissues, 10 cases_24 cores; ihc Anti-Cytokeratin (CK) confirmed
BL241 Bladder cancer tissue array with self_matching normal adjacent tissues, 10 cases_24 cores
BL481 Bladder cancer tissue array with unmatched normal adjacent tissues, 48 cases_48 cores, with stage and grade data
BL481 Bladder cancer tissue array with unmatched normal adjacent tissues, 48 cases_48 cores, with stage and grade data; ihc Anti-Actin confirmed
BLC241 Bladder cancer tissue array, 12 cases_24 cores
BLC241 Bladder cancer tissue array, 12 cases_24 cores; ihc H&E, IHC anti-Cytokeratin
BLC661 Bladder cancer tissue array, 33 cases_66 cores
BLC661 Bladder cancer tissue array, 33 cases_66 cores; ihc H&E, IHC anti-Vimentin_Cytokeratin
BL482 Bladder cancer tissue array, including TNM and pathology grade, 48 cases_48 cores
BL482 Bladder cancer tissue array, including TNM and pathology grade, 48 cases_48 cores; ihc Anti-Actin confirmed
T125 Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases_24 cores; ihc Anti-Actin confirmed
BC12011a Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 63 cases_63 cores, replacing BC12011; ihc Anti-Actin confirmed
BL1501 Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases_150 cores; ihc Anti-Actin confirmed
BL806 Bladder cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 80 cases_80 cores, replacing BL801
BL801 Bladder cancer tissue array, with adjacent normal tissue, pathology grade and TNM stage, 53 cases_80 cores, replaced by BL806
BL801 Bladder cancer tissue array, with adjacent normal tissue, pathology grade and TNM stage, 53 cases_80 cores, replaced by BL806; ihc Anti-Cytokeratin (CK) confirmed
BL806 Bladder cancer tissue array, with matched adjacent normal tissue (NAT), including TNM and pathology grade, 80 cases_80 cores, replacing BL801; ihc Anti-Actin confirmed
BL242 Bladder cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases_48 cores
BL242 Bladder cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases_48 cores; ihc Anti-Actin confirmed
BC12012 Bladder carcinoma (multi-tissue combined panel) tissue array, 63 cases_63 cores, replaced by BL802; ihc Anti-PCNA confirmed
BC12012 Bladder carcinoma (multi_tissue combined panel) tissue array, 63 cases_63 cores, replaced by BL802
BL2082 Bladder disease spectrum (bladder cancer progression) tissue array, 202 cases_208 cores
BL2082 Bladder disease spectrum (bladder cancer progression) tissue array, 202 cases_208 cores; ihc Anti-Actin confirmed
BL804 Bladder disease spectrum (urocystic cancer progression) tissue array, 80 cases_80 cores
BL804 Bladder disease spectrum (urocystic cancer progression) tissue array, 80 cases_80 cores; ihc Anti-Actin confirmed
MC809a Blastoma tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 80 cases_80 cores, replacing MC809; ihc Anti-Actin confirmed
SO8010 Blood vessel disease spectrum (blood vessel cancer progression) tissue array, 80 cases_80 cores
SO8010 Blood vessel disease spectrum (blood vessel cancer progression) tissue array, 80 cases_80 cores; ihc Anti-Actin confirmed
T261 Bone and cartilage cancer test tissue array, with normal bone and cartilage tissue as control, including TNM, clinical stage and pathology grade, 6 cases_24 cores
T261 Bone and cartilage cancer test tissue array, with normal bone and cartilage tissue as control, including TNM, clinical stage and pathology grade, 6 cases_24 cores; ihc Anti-Actin confirmed
BO241 Bone and cartilage cancer tissue array with unmatched normal adjacent tissues, 12 cases_24 cores
BO241 Bone and cartilage cancer tissue array with unmatched normal adjacent tissues, 12 cases_24 cores; ihc Anti-Vimentin (Vim) confirmed
BO801 Bone and cartilage disease spectrum (bone and cartilage cancer progression) tissue array, 80 cases_80 cores
BO801 Bone and cartilage disease spectrum (bone and cartilage cancer progression) tissue array, 80 cases_80 cores; ihc Anti-Actin confirmed
BO481 Bone and cartilage tumor tissue array with unmatched normal tissue, 48 cases_48 cores with TNM data
BO481 Bone and cartilage tumor tissue array with unmatched normal tissue, 48 cases_48 cores with TNM data; ihc Anti-Actin confirmed
T263 Bone and cartilage tumor tissue array, with normal tissue, including TNM, 6 cases_24 cores
T263 Bone and cartilage tumor tissue array, with normal tissue, including TNM, 6 cases_24 cores; ihc Anti-Actin confirmed
T262 Bone cancer test tissue array, with normal control tissue, including TNM and clinical stage, 12 cases_24 cores
T262 Bone cancer test tissue array, with normal control tissue, including TNM and clinical stage, 12 cases_24 cores; ihc Anti-Actin confirmed
BO2081 Bone disease spectrum (bone tumor progression) tissue array, 104 cases_208 cores
BO2081 Bone disease spectrum (bone tumor progression) tissue array, 104 cases_208 cores; ihc Anti-Actin confirmed
BO601 Bone giant cell tumor tissue array, 30 cases_60 cores
BO601 Bone giant cell tumor tissue array, 30 cases_60 cores; ihc Anti-Vimtin confirmed
BM241 Bone marrow tissue array, 12 cases_24 cores
BM241 Bone marrow tissue array, 12 cases_24 cores; ihc Anti-Actin confirmed
BM483 Bone marrow tumor and adjacent normal tissue array, including TNM and pathology grade, 24 cases_48 cores, replacing BM482
BM483 Bone marrow tumor and adjacent normal tissue array, including TNM and pathology grade, 24 cases_48 cores, replacing BM482; ihc Anti-Actin confirmed
T293 Bone marrow tumor and normal tissue array, including TNM, 6 cases_24 cores
T293 Bone marrow tumor and normal tissue array, including TNM, 6 cases_24 cores; ihc Anti-Actin confirmed
BC17013 Brain astrocytoma and meningioma tissue array, 120 cases_120 cores
BC17013 Brain astrocytoma and meningioma tissue array, 120 cases_120 cores
BC17013 Brain astrocytoma and meningioma tissue array, 120 cases_120 cores; ihc Anti-Actin confirmed
T173a Brain cancer test tissue array, with normal tissue as control, including TNM and pathology grade, 2 serial sections, 6 cases_24 cores, replacing T173; ihc Anti-Actin confirmed
T172 Brain cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases_24 cores
T172 Brain cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases_24 cores, replaced by T175; ihc Anti-Actin confirmed
T173 Brain cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases_24 cores
T173 Brain cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases_24 cores, replaced by T173a; ihc Anti-Actin confirmed
CNS801 Brain disease spectrum (brain cancer progression) tissue array, with stage, TNM and grade info, 79 cases_80 cores
CNS801 Brain disease spectrum (brain cancer progression) tissue array, with stage, TNM and grade info, 79 cases_80 cores; ihc Anti-Actin confirmed
GL806 Brain glioblastoma and normal tissue array, 40 cases_80 cores, replacing GL805
GL806 Brain glioblastoma multiforme(GBM) tissue array, 40 cases_80 cores, replaced by GL806a; ihc Anti-Actin confirmed
GL806a Brain glioblastoma multiforme(GBM) tissue array, 40 cases_80 cores, replacing GL806; ihc Anti-Actin confirmed
BS17011 Brain glioblastoma tissue array, 21 cases_63 cores, replaced by GL811
BS17011 Brain glioblastoma tissue array, 21 cases_63 cores, replaced by GL811; ihc Anti-GFAP confirmed
BS17018 Brain glioblastoma tissue array, 33 cases_63 cores, replaced by GL805
BS17018 Brain glioblastoma tissue array, 33 cases_63 cores, replaced by GL805; ihc Anti-Glial Fibrillary Acid Protein (GFAP) confirmed
BS17016a Brain glioblastoma tissue array, including pathology grade, 40 cases_80 cores, replacing BS17016; ihc Anti-Actin confirmed
BS17017 Brain gliocytoma tissue array, 63 cases_63 cores
BS17017 Brain gliocytoma tissue array, 63 cases_63 cores; ihc Anti-Glial Fibrillary Acid Protein (GFAP) confirmed
GL722 Brain glioma (astrocytoma) tissue array, 24 cases_72 cores
GL722 Brain glioma (astrocytoma) tissue array, 24 cases_72 cores; ihc Anti-Actin confirmed
GL807 Brain glioma and normal tissue array, including pathology grade, 40 cases_80 cores
GL807 Brain glioma and normal tissue array, including pathology grade, 40 cases_80 cores; ihc Anti-Actin confirmed
T171 Brain glioma test tissue array, with normal brain tissues as control, including pathology grade, 6 cases_24 cores, replaced by T174
T171 Brain glioma test tissue array, with normal brain tissues as control, including pathology grade, 6 cases_24 cores, replaced by T174a; ihc Anti-Actin confirmed
BS17016 Brain glioma tissue array, 33 cases_63 cores
BS17016 Brain glioma tissue array, 33 cases_63 cores, replaced by BS17016a; ihc Anti-GFAP confirmed
BS17015 Brain glioma tissue array, 63 cases_63 cores, replaced by GL803
BS17015 Brain glioma tissue array, 63 cases_63 cores, replaced by GL803; ihc Anti-GFAP confirmed
GL801 Brain glioma tissue array, with matched or unmatched adjacent normal tissue, 76 cases_80 cores
GL801 Brain glioma tissue array, with matched or unmatched adjacent normal tissue, 76 cases_80 cores; ihc Anti-Glial Fibrillary acid protein antibody confirmed
GL208 Brain primary tumor high density (69 cases_208 cores) tissue microarray of astrocytoma, glioblastoma, glioblastoma multiforme (GBM) and normal tissue
GL208 Brain primary tumor high density (69 cases_208 cores) tissue microarray of astrocytoma, glioblastoma, glioblastoma multiforme (GBM) and normal tissue; ihc Anti-Actin confirmed
GL2082 Brain tumor (meningioma, astrocytoma and glioblastoma) tissue array, 104 cases_208 cores
GL2082 Brain tumor (meningioma, astrocytoma and glioblastoma) tissue array, 104 cases_208 cores; ihc Anti-Actin confirmed
GL803a Brain tumor and adjacent normal tissue array, including pathology grade, 80 cases_80 cores, replacing GL803; ihc Anti-Actin confirmed
GL804 Brain tumor and normal tissue array with grade and TNM data, 40 cases_80 cores
GL804 Brain tumor and normal tissue array with grade and TNM data, 40 cases_80 cores; ihc Anti-Cytokeratin (CK) confirmed
GL2083 Brain tumor and normal tissue array with pathology grade, 208 cases_208 cores
GL2083 Brain tumor and normal tissue array with pathology grade, 208 cases_208 cores, replaced by GL2083a; ihc Anti-Cytokeratin (CK) confirmed
GL721 Brain tumor and normal tissue array with TNM and grade info, 24 cases_72 cores
GL721 Brain tumor and normal tissue array with TNM and grade info, 24 cases_72 cores; ihc Anti-Cytokeratin (CK) confirmed
GL1002 Brain tumor and normal tissue array, 50 cases_100 cores
GL1002 Brain tumor and normal tissue array, 50 cases_100 cores; ihc Anti-Actin confirmed
GL811 Brain tumor and normal tissue array, with pathology grade, 27 cases_81 cores, replacing BS17011
GL811 Brain tumor and normal tissue array, with pathology grade, 27 cases_81 cores, replacing BS17011; ihc Anti-Actin confirmed
T174 Brain tumor test tissue array, with normal tissue, including TNM and pathology grade, 6 cases_24 cores, replacing T171
T174 Brain tumor test tissue array, with normal tissue, including TNM and pathology grade, 6 cases_24 cores, replacing T171; ihc Anti-Actin confirmed
GL1003 Brain tumor tissue array for antibody screening, 25 cases_100 cores
GL1003 Brain tumor tissue array for antibody screening, 25 cases_100 cores; ihc Anti-Actin confirmed
GL803 Brain tumor tissue array of glioblastoma, astrocytoma, ependymoma, oligo astrocytoma, medulloblastoma and oligodendroglioma, 78 cases_80 cores, replaced by GL803a; ihc Anti-Glial Fibrillary Acid Prot
GL803 Brain tumor tissue array of glioblastoma, astrocytoma, ependymoma, oligo astrocytoma, medulloblastoma and oligodendroglioma, 78 cases_80 cores, replacing BS17015
GL241a Brain tumor tissue array with adjacent normal brain tissue, including pathology grade, 10 cases_24 cores, replacing GL241; ihc Anti-Actin confirmed
T175 Brain tumor tissue array with normal brain tissue as control, including pathology grade, 12 cases_24 cores, replacing T172; ihc Anti-Actin confirmed
T174a Brain tumor tissue array with normal brain tissue as control, including pathology grade, 6 cases_24 cores, replacing T171; ihc Anti-Actin confirmed
T176 Brain tumor tissue array, including pathology grade, 6 cases_24 cores; ihc Anti-Actin confirmed
GL2083a Brain tumor tissue array, including TNM, clinical stage and pathology grade, 208 cases_208 cores, replacing GL2083; ihc Anti-Cytokeratin (CK) confirmed
GL808 Brain tumor tissue array, with matched adjacent normal tissue, 80 cases_80 cores
GL808 Brain tumor tissue array, with matched adjacent normal tissue, 80 cases_80 cores; ihc Anti-Cytokeratin (CK) confirmed
GL242 Brain tumor tissue array, with normal tissue, 2 serial sections, 24 cases_48 cores
GL242 Brain tumor tissue array, with normal tissue, 2 serial sections, 24 cases_48 cores; ihc Anti-Cytokeratin (CK) confirmed
GL482 Brain tumor tissue array, with normal tissue, 48 cases_48 cores
GL482 Brain tumor tissue array, with normal tissue, 48 cases_48 cores; ihc Anti-Cytokeratin (CK) confirmed
FMS151 Brains of multiple species frozen tissue array, 14 cases_15 cores
FMS151 Brains of multiple species frozen tissue array, 14 cases_15 cores; ihc Anti-Actin confirmed
BRN801a Breast adjacent normal tissue array with breast cancer tissue, including TNM, clinical stage and pathology grade, 80 cases_80 cores, replacing BRN801; ihc Anti-Actin confirmed
BC081116 Breast cancer (IDC) tissue array, with adjacent normal tissue, including TNM and pathology grade, 110 cases_110 cores
BC081116 Breast cancer (IDC) tissue array, with adjacent normal tissue, including TNM and pathology grade, 110 cases_110 cores; ihc Anti-Actin confirmed
BC08014 Breast cancer (multiple types of breast cancer) tissue array, 63 cases_63 cores, replaced by BR8018
BC08014 Breast cancer (multiple types of breast cancer) tissue array, 63 cases_63 cores, replaced by BR8018; ihc Anti-Actin confirmed
BR243 Breast cancer and adjacent normal tissue array, 6 cases_24 cores, replaced by BR243a
BR243 Breast cancer and adjacent normal tissue array, 6 cases_24 cores, replacing BR241; ihc Anti-Actin confirmed
BC081120 Breast cancer and adjacent normal tissue array, including TNM and pathology grade, 110 cases_110 cores, replacing BC081115
BC081120 Breast cancer and adjacent normal tissue array, including TNM and pathology grade, 110 cases_110 cores, replacing BC081115; ihc Anti-Actin confirmed
BR1005a Breast cancer and matched metastatic carcinoma of lymph node tissue array, including TNM, clinical stage and pathology grade, 50 cases_100 cores, replacing BR1005; ihc Anti-Actin confirmed
BR1005 Breast cancer and matched metastatic carcinoma of lymph node, 50 cases_100 cores, no overlaps with BR1001 or BR1004
BR1005 Breast cancer and matched metastatic carcinoma of lymph node, 50 cases_100 cores, no overlaps with BR1001 or BR1004, replaced by BR1005a; ihc Anti-Actin confirmed
BR10010 Breast cancer and matched metastatic carcinoma tissue array, including TNM and pathology grade, 50 cases_100 cores, replacing BR1004
BR10010 Breast cancer and matched metastatic carcinoma tissue array, including TNM and pathology grade, with ER, PR and Her-2 (neu) IHC results, 50 cases_100 cores, replaced by BR10010a; ihc Anti-Actin confi
BR10010a Breast cancer and matched metastatic carcinoma tissue array, including TNM and pathology grade, with ER, PR and Her-2 (neu) IHC results, 50 cases_100 cores, replacing BR10010; ihc Anti-Actin confirme
BR8012 Breast cancer and normal tissue array with stage and grade info, 40 cases_80 cores, replaced by BR8014
BR8012 Breast cancer and normal tissue array with stage and grade info, 40 cases_80 cores, replaced by BR8014; ihc Anti-Actin confirmed
BRC481 Breast cancer and normal tissue array, 16 cases_48 cores
BRC481 Breast cancer and normal tissue array, 16 cases_48 cores; ihc H&E, IHC anti-Cytokeratin
BR485 Breast cancer and normal tissue array, including TNM and pathology grade, 2 serial sections, 48 cases_96 cores
BR485 Breast cancer and normal tissue array, including TNM and pathology grade, 2 serial sections, 48 cases_96 cores; ihc Anti-Actin confirmed
BR2086 Breast cancer and normal tissue array, including TNM, clinical stage and pathology grade, 208 cases_208 cores, replacing BR2001
BR2086 Breast cancer and normal tissue array, including TNM, clinical stage and pathology grade, 208 cases_208 cores, replacing BR2001; ihc Anti-Actin confirmed
BR8014 Breast cancer and normal tissue array, including TNM, clinical stage and pathology grade, 40 cases_80 cores, replacing BR8012
BR8014 Breast cancer and normal tissue array, including TNM, clinical stage and pathology grade, 40 cases_80 cores, replacing BR8012; ihc Anti-Actin confirmed
BRC962 Breast cancer and normal tissue array, non-overlapping with BRC961, with TNM data, 48 cases_96 cores; ihc H&E, IHC anti-Cytokeratin
BRC962 Breast cancer and normal tissue array, non_overlapping with BRC961, with TNM data, 48 cases_96 cores
BR727 Breast cancer and normal tissue array, with TNM, stage and grade info, 24 cases_72 cores, replacing BS08011
BR727 Breast cancer and normal tissue array, with TNM, stage and grade info, 24 cases_72 cores, replacing BS08011; ihc Anti-Actin confirmed
BRC961 Breast cancer array with normal and other non-malignant breast tissues, non-overlapping with BRC962, with AR_ER_PR_Her-2(neu) IHC results, 48 cases_96 cores; ihc H&E, IHC anti-Cytokeratin
BR962 Breast cancer array with normal and other non-malignant breast tissues, with AR, ER, PR, Her-2 (neu) IHC results, 48 cases_96 cores, replaced by BR963; ihc Anti-Vimentin_Cytokeratin confirmed
BRC961 Breast cancer array with normal and other non_malignant breast tissues, non_overlapping with BRC962, with AR_ER_PR_Her_2(neu) IHC results, 48 cases_96 cores
BR961 Breast cancer array with normal and other non_malignant breast tissues, with AR, ER, PR, Her_2 (neu) IHC results, 48 cases_96 cores, replaced by BR962
BR962 Breast cancer array with normal and other non_malignant breast tissues, with AR, ER, PR, Her_2 (neu) IHC results, 48 cases_96 cores, replacing BR961, BR701
BRF401 Breast cancer frozen tissue array, with normal tissue, 40 cases_40 cores, Her-2 and ER_PR IHC are supplied when purchase; ihc Anti-Actin confirmed
BRF401i Breast cancer frozen tissue array, with normal tissue, 40 cases_40 cores, Her-2 and ER_PR IHC are supplied when purchase; ihc Anti-Actin confirmed
BR2001 Breast cancer high-density tissue array, 196 cases_200 cores, replaced by BR2086; ihc Anti-Proliferating Cell Nuclear Antigen (PCNA) confirmed
BR2001 Breast cancer high_density tissue array, 196 cases_200 cores, replaced by BR2086
BRC1503 Breast cancer mid-density tissue array, non-overlapping with BRC1501 or BRC1502, 75 cases_150 cores; ihc H&E, IHC anti-Cytokeratin
BRC1502 Breast cancer mid-density tissue array, non-overlapping with either BRC1501 or BRC1503, 75 cases_150 cores; ihc H&E, IHC anti-Cytokeratin
BRC1501 Breast cancer mid-density tissue array, non-overlapping with either BRC1502 or BRC1503, 75 cases_150 cores; ihc H&E, IHC anti-Cytokeratin
BR1502 Breast cancer mid-density tissue array, wiht AR_ER_PR_Her-2_P53_EGFR_Ki67 IHC results, 75 cases_150 cores, replaced by BR1503; ihc Anti-Vimentin_Cytokeratin confirmed
BRC1503 Breast cancer mid_density tissue array, non_overlapping with BRC1501 or BRC1502, 75 cases_150 cores
BRC1502 Breast cancer mid_density tissue array, non_overlapping with either BRC1501 or BRC1503, 75 cases_150 cores
BRC1501 Breast cancer mid_density tissue array, non_overlapping with either BRC1502 or BRC1503, 75 cases_150 cores
BR1502 Breast cancer mid_density tissue array, wiht AR_ER_PR_Her_2_P53_EGFR_Ki67 IHC results, 75 cases_150 cores, replaced by BR1503
T089 Breast cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases_24 cores; ihc Anti-Actin confirmed
BR241 Breast cancer test tissue array with self-matched or unmatched normal adjacent tissues, 6 cases_24 cores.; ihc Anti-Cytokeratin (CK) confirmed
BR241 Breast cancer test tissue array with self_matched or unmatched normal adjacent tissues, 6 cases_24 cores.
T086b Breast cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases_24 cores, replacing T086a; ihc Anti-Actin confirmed
T081 Breast cancer test tissue array, with normal breast tissues as control, including TNM, clinical stage and pathology grade, 6 cases_24 cores, replaced by T085
T081 Breast cancer test tissue array, with normal breast tissues as control, including TNM, clinical stage and pathology grade, 6 cases_24 cores, replaced by T085; ihc Anti-Actin confirmed
T084 Breast cancer test tissue array, with normal control tissue, with TNM, Grade and Stage, 12 cases_24 cores, replaced by T086a; ihc Anti-Actin confirmed
T084 Breast cancer test tissue array, with normal control tissue, with TNM, Grade and Stage, 12 cases_24 cores, replacing T082
T083 Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases_24 cores
T083 Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases_24 cores, replaced by T087; ihc Anti-Actin confirmed
T087 Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases_24 cores, replaced by T087a; ihc Anti-Actin confirmed
T087a Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases_24 cores, replacing T087; ihc Anti-Actin confirmed
T085 Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 6 cases_24 cores, replaced by T088
T085 Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 6 cases_24 cores, replaced by T088; ihc Anti-Actin confirmed
T082 Breast cancer test tissue array, with normal tissue as control, including TNM, stage and grade, 12 cases_24 cores, replaced by T084
T082 Breast cancer test tissue array, with normal tissue as control, including TNM, stage and grade, 12 cases_24 cores, replaced by T084; ihc Anti-Actin confirmed
T086 Breast cancer test tissue array, with normal tissue, including TNM and pathology grade, 12 cases_24 cores, replacing T084
T086 Breast cancer test tissue array, with normal tissue, including TNM and pathology grade, 12 cases_24 cores, replacing T084, replaced by T086a; ihc Anti-Actin confirmed
BR726 Breast cancer tissue array and normal tissue array, with TNM and grade, 24 cases_72 cores
BR726 Breast cancer tissue array and normal tissue array, with TNM and grade, 24 cases_72 cores; ihc Anti-Actin confirmed
BRC51 Breast cancer tissue array BLOCK, Her-2 IHC marker; ihc Anti-Cytokeratin (CK) confirmed
BRM961 Breast cancer tissue array containing primary and matched metastatic tumors (in lymph nodes) and adjacent normal breast tissue, 48 casea_96 cores
BRM961 Breast cancer tissue array containing primary and matched metastatic tumors (in lymph nodes) and adjacent normal breast tissue, 48 casea_96 cores; ihc H&E, IHC anti-Cytokeratin
BR1009 Breast cancer tissue array for antibody screening , including TNM and pathology grade, 50 cases_100 cores
BR1009 Breast cancer tissue array for antibody screening , including TNM and pathology grade, 50 cases_100 cores; ihc Anti-Actin confirmed
BR1007 Breast cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases_100 cores
BR1007 Breast cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases_100 cores; ihc Anti-Actin confirmed
BR243e Breast cancer tissue array with adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases_24 cores, replacing BR243a; ihc Anti-Actin confirmed
BR244 Breast cancer tissue array with adjacent normal tissues, with TNM and grade info, 12 cases_24 cores, replaced by BR245
BR244 Breast cancer tissue array with adjacent normal tissues, with TNM and grade info, 12 cases_24 cores, replaced by BR245; ihc Anti-Actin confirmed
BR041 Breast cancer tissue array with HER2 IHC control, including TNM and pathology grade, 4 cases_4 cores, replaced by BR042a
BR041 Breast cancer tissue array with HER2 IHC control, including TNM and pathology grade, 4 cases_4 cores, replaced by BR042a; ihc Anti-Actin confirmed
BR082 Breast cancer tissue array with HER2 IHC control, including TNM and pathology grade, 4 cases_8 cores
BR082 Breast cancer tissue array with HER2 IHC control, including TNM and pathology grade, 4 cases_8 cores; ihc Anti-Actin confirmed
BR243c Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases_24 cores, replaced by BR243d; ihc Anti-Actin confirmed
BR243f Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases_24 cores, replacing BR243a; ihc Anti-Actin confirmed
BR243d Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases_24 cores, replacing BR243c; ihc Anti-Actin confirmed
BR1001 Breast cancer tissue array with matched carcinoma metastasis to lymph nodes, 50 cases_100 cores, replaced by BR1004
BR1001 Breast cancer tissue array with matched carcinoma metastasis to lymph nodes, 50 cases_100 cores, replaced by BR1004; ihc Anti-Cytokeratin (Low MW) confirmed
BR952 Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER_PR_p53 IHC results and survival data, 31 cases_95 cores
BR951 Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER_PR_p53 IHC results and survival data, 31 cases_95 cores, replaced by BR952; ihc
BR953 Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER_PR_p53 IHC results and survival data, 31 cases_95 cores, replaced by BR954; ihc
BR953 Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER_PR_p53 IHC results and survival data, 31 cases_95 cores, replacing BR952
BR954 Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER_PR_p53 IHC results and survival data, 31 cases_95 cores, replacing BR953; ihc
BR951 Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER_PR_p53 IHC results and survival data, 31 cases_95 cores, to be replaced by BR95
BR952 Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER_PR_p53 IHC results and survival data, 31 cases_95 cores; ihc Anti-Actin confir
BR812 Breast cancer tissue array with normal tissues from autopsy, 40 cases_80 cores, with TNM data
BR812 Breast cancer tissue array with normal tissues from autopsy, 40 cases_80 cores, with TNM data; ihc Anti-Actin confirmed
BR811 Breast cancer tissue array with normal tissues from autopsy, 80 cases_80 cores, with grade and stage data
BR811 Breast cancer tissue array with normal tissues from autopsy, 80 cases_80 cores, with grade and stage data; ihc Anti-Actin confirmed
BR721 Breast cancer tissue array with self-matching adjacent tissue and normal tissue, 24 cases_72 cores, no overlaps with other BR TMAs; ihc Anti-Cytokeratin (CK) confirmed
BR721 Breast cancer tissue array with self_matching adjacent tissue and normal tissue, 24 cases_72 cores, no overlaps with other BR TMAs
BRC1021 Breast cancer tissue array, 102 cases_102 cores
BRC1021 Breast cancer tissue array, 102 cases_102 cores; ihc H&E, IHC anti-Cytokeratin
BR641 Breast cancer tissue array, 64 cases_66 cores, with TNM data
BR701 Breast cancer tissue array, 70 cases_70 cores, with TNM data plus ER, PR and Her-2 (C-erbB-2, neu<_em>) IHC results, replaced by BR962; ihc Anti-Actin confirmed
BR701 Breast cancer tissue array, 70 cases_70 cores, with TNM data plus ER, PR and Her_2 (C_erbB_2, neu<_em>) IHC results, replaced by BR962
BR2161 Breast cancer tissue array, including TNM and pathology grade, 216 cases_216 cores
BR2161 Breast cancer tissue array, including TNM and pathology grade, 216 cases_216 cores; ihc Anti-Actin confirmed
BR042a Breast cancer tissue array, including TNM and pathology grade, 4 cases_4 cores
BR042a Breast cancer tissue array, including TNM and pathology grade, 4 cases_4 cores; ihc Anti-Actin confirmed
BR484 Breast cancer tissue array, including TNM and pathology grade, 48 cases_48 cores
BR484 Breast cancer tissue array, including TNM and pathology grade, 48 cases_48 cores; ihc Anti-Actin confirmed
BR1503 Breast cancer tissue array, including TNM and pathology grade, 75 cases_150 cores, replaced by BR1503a; ihc Anti-Cytokeratin (CK) confirmed
BR1503 Breast cancer tissue array, including TNM and pathology grade, with IHC results of Her_2, ER, PR, P53 and Ki_67, 75 cases_150 cores, replacing BR1502
BR246 Breast cancer tissue array, including TNM, clinical stage and pathology grade, 12 cases_24 cores, replaced by BR246a
BR246 Breast cancer tissue array, including TNM, clinical stage and pathology grade, 12 cases_24 cores, replaced by BR246a; ihc Anti-Actin confirmed
BR804a Breast cancer tissue array, including TNM, clinical stage and pathology grade, 40 cases_80 cores, replacing BR804; ihc Anti-Actin confirmed
BR964 Breast cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases_96 cores; ihc Anti-Actin confirmed
BR1503a Breast cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases_150 cores, with IHC results of Her-2, ER, PR, AR, P53 and Ki67, 75 cases_150 cores, replacing BR1503; ihc Anti-
BR803a Breast cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases_80 cores, replacing BR803; ihc Anti-Actin confirmed
BR1505 Breast cancer tissue array, including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2, AR and Ki67) results, 75 cases_150 cores, no overlaps with BR1503 or BR1504; ihc Anti-Actin
BR8015 Breast cancer tissue array, with adjacent normal tissue and normal tissue, including TNM and pathology grade, 80 cases_80 cores, replacing BC08014
BR8015 Breast cancer tissue array, with adjacent normal tissue and normal tissue, including TNM and pathology grade, 80 cases_80 cores, replacing BC08014; ihc Anti-Actin confirmed
BC081115 Breast cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 110 cases_110 cores, replaced by BC081120
BC081115 Breast cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 110 cases_110 cores, replaced by BC081120; ihc Anti-Actin confirmed
BR802 Breast cancer tissue array, with matched or unmatched adjacent normal tissue array, 40 cases_80 cores, no overlaps with BR801, BR803 and BR1001, replaced by BR802b
BR802 Breast cancer tissue array, with matched or unmatched adjacent normal tissue array, 40 cases_80 cores, no overlaps with BR801, BR803 and BR1001, replaced by BR802b; ihc Anti-Cytokeratin (High MW) con
BR2085c Breast cancer tissue array, with normal tissue and adjacent normal tissue, including TNM and pathology grade, 188 cases_208 cores, replacing BR2085a
BR2085c Breast cancer tissue array, with normal tissue and adjacent normal tissue, including TNM and pathology grade, 188 cases_208 cores, replacing BR2085a; ihc Anti-Actin confirmed
T088 Breast cancer tissue array, with normal tissue as control, including TNM and pathology grade, 6 cases_24 cores, replacing T085
T088 Breast cancer tissue array, with normal tissue as control, including TNM and pathology grade, 6 cases_24 cores, replacing T085; ihc Anti-Actin confirmed
BR247 Breast cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases_48 cores, 2 sections_sllide
BR247 Breast cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases_48 cores, 2 sections_sllide; ihc Anti-Actin confirmed
BR451 Breast cancer tissue microarray with matched normal adjacent tissue and metastatic lymph nodes, 45cases_45 cores, with ER, PR and P53 IHC results
BR451 Breast cancer tissue microarray with matched normal adjacent tissue and metastatic lymph nodes, 45cases_45 cores, with ER, PR and P53 IHC results; ihc Anti-Cytokeratin (CK) confirmed
BR724 Breast cancer, adjacent and adjacent normal tissue array, 66 cases_72 cores
BR724 Breast cancer, adjacent and adjacent normal tissue array, 66 cases_72 cores; ihc Anti-Actin confirmed
BR725 Breast cancer, adjacent and adjacent normal tissue array, 68 cases_72 cores
BR725 Breast cancer, adjacent and adjacent normal tissue array, 68 cases_72 cores; ihc Anti-Actin confirmed
BR1008 Breast cancer, carcinoma metastasize to lymph nodes and adjacent normal tissue array, including TNM and pathology grade, 100 cases_100 cores, replacing BC08212
BR1008 Breast cancer, carcinoma metastasize to lymph nodes and adjacent normal tissue array, including TNM and pathology grade, 100 cases_100 cores, replacing BC08212; ihc Anti-Actin confirmed
BC08022 Breast carcinoma (combination of adjacent and normal) tissue array, 53 cases_63 cores, replacing BN08021
BC08022 Breast carcinoma (combination of adjacent and normal) tissue array, 53 cases_63 cores, replacing BN08021; ihc Anti-ER confirmed
BC08023 Breast carcinoma (combination of adjacent and normal) tissue array, 57 cases_63 cores
BC08023 Breast carcinoma (combination of adjacent and normal) tissue array, 57 cases_63 cores; ihc Anti-Cytokeratin (Low-MW) confirmed
BC08015 Breast carcinoma (multi-tissue combined panel) tissue array, 22 cases_63 cores, replaced by BR728; ihc Anti-PCNA confirmed
BC08013 Breast carcinoma (multi-tissue combined panel) tissue array, 63 cases_63 cores, replaced by BC08014; ihc Anti-ER confirmed
BC08016 Breast carcinoma (multi-tissue combined panel) tissue array, 63 cases_63 cores, replaced by BR803; ihc Anti-Cytokeratin (Low-MW) confirmed
BR803 Breast carcinoma (multi-tissue combined panel) tissue array, 79 cases_80 cores, replaced by BR803a; ihc Anti-Cytokeratin (Low-MW) confirmed
BC08015 Breast carcinoma (multi_tissue combined panel) tissue array, 22 cases_63 cores, replaced by BR728
BC08013 Breast carcinoma (multi_tissue combined panel) tissue array, 63 cases_63 cores, replaced by BC08014
BC08016 Breast carcinoma (multi_tissue combined panel) tissue array, 63 cases_63 cores, replaced by BR803
BR803 Breast carcinoma (multi_tissue combined panel) tissue array, 79 cases_80 cores, replacing BC08016
BR245 Breast carcinoma tissue array, including TNM, clinical stage and pathology grade, 12 cases_24 cores, replaced by BR246
BR245 Breast carcinoma tissue array, including TNM, clinical stage and pathology grade, 12 cases_24 cores, replaced by BR246; ihc Anti-Actin confirmed
BR728 Breast carcinoma tissue array, with stage and grade info, 24 cases_72 cores, replacing BC08015
BR728 Breast carcinoma tissue array, with stage and grade info, 24 cases_72 cores, replacing BC08015; ihc Anti-Actin confirmed
BR2082 Breast disease spectrum (breast cancer progression) tissue array, 206 cases_208 cores
BR2082 Breast disease spectrum (breast cancer progression) tissue array, 206 cases_208 cores; ihc Anti-Actin confirmed
BR480 Breast disease spectrum tissue array - progression array, 48 cases_48 cores; ihc Anti-Actin confirmed
BR480 Breast disease spectrum tissue array _ progression array, 48 cases_48 cores
BR722 Breast disease spectrum tissue array, 66 cases_72 cores, including normal, precancerous and cancer in different stages
BR722 Breast disease spectrum tissue array, 66 cases_72 cores, including normal, precancerous and cancer in different stages; ihc Anti-Cytokeratin (CK) confirmed
BR963 Breast disease spectrum tissue array, including TNM and pathology grade, stage, TNM and IHC markers (AR, PR, ER, Her-2, Ki67, CK14 and p53), 48 cases_96 cores, replaced by BR963a; ihc Anti-Actin conf
BR963 Breast disease spectrum tissue array, including TNM and pathology grade, stage, TNM and IHC markers (AR, PR, ER, Her_2, Ki67, CK14 and p53), 48 cases_96 cores, replacing BR962
BR963a Breast disease spectrum tissue array, including TNM, clinical stage and pathology grade, 48 cases_96 cores, replacing BR963; ihc Anti-Actin confirmed
BRD181 Breast disease tissue array, 18 cases_18 cores
BRD181 Breast disease tissue array, 18 cases_18 cores; ihc H&E, IHC anti-Cytokeratin
BR8010 Breast fibroadenoma tissue array (including normal, lobular, invasive carcinoma and metastasis in lymph nodes), 71 cases_80 cores
BR8010 Breast fibroadenoma tissue array (including normal, lobular, invasive carcinoma and metastasis in lymph nodes), 71 cases_80 cores; ihc Anti-Actin confirmed
BR601 Breast fibroma and sclerosing adenosis tissue microarray, 30 cases_60 cores
BR601 Breast fibroma and sclerosing adenosis tissue microarray, 30 cases_60 cores; ihc Anti-Smooth Muscle Actin (SMA) confirmed
BN08111 Breast hyperplasia and normal tissue array, 10 cases_30 cores
BN08111 Breast hyperplasia and normal tissue array, 10 cases_30 cores; ihc Anti-Actin confirmed
BR806 Breast hyperplasia tissue array, 80 cases_80 cores
BR806 Breast hyperplasia tissue array, 80 cases_80 cores; ihc Anti-Cytokeratin (CK) confirmed
BR481 Breast infiltrating ductal carcinoma not otherwise specified (NOS) and matched adjacent, 12 cases_48 cores
BR481 Breast infiltrating ductal carcinoma not otherwise specified (NOS) and matched adjacent, 12 cases_48 cores; ihc Anti-actin confirmed Certified pathologist code Certified pathologist code
BS08011 Breast infiltrating ductal carcinoma tissue array, 22 cases_63 cores, replaced by BR727
BS08011 Breast infiltrating ductal carcinoma tissue array, 22 cases_63 cores, replaced by BR727 ; ihc Anti-ER confirmed
BR805 Breast infiltrating lobular carcinoma tissue array, 80 cases_80 cores
BR805 Breast infiltrating lobular carcinoma tissue array, 80 cases_80 cores; ihc Anti-Cytokeratin (CK) confirmed
BR8011 Breast intraductal carcinoma tissue microarray with normal adjacent tissue, 80 cases_80 cores
BR8011 Breast intraductal carcinoma tissue microarray with normal adjacent tissue, 80 cases_80 cores; ihc Anti-Actin confirmed
BRF404 Breast invasive ductal carcinoma forzen tissue array, 20 cases_40 cores
BRF404 Breast invasive ductal carcinoma forzen tissue array, 20 cases_40 cores; ihc Anti-Actin confirmed
T086a Breast invasive ductal carcinoma test tissue array, with normal tissue, including TNM and pathology grade, 12 cases_24 cores, replaced by T086b; ihc Anti-Actin confirmed
BR486 Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 16 cases_48 cores
BR486 Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 16 cases_48 cores
BR486 Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 16 cases_48 cores; ihc Anti-Actin confirmed
BR243a Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 6 cases_24 cores, replaced by BR243f; ihc Anti-Actin confirmed
BR243a Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 6 cases_24 cores, replacing BR243
BR243a Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 6 cases_24 cores, replacing BR243
BR243b Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 6 cases_24 cores, replacing BR243; ihc Anti-Actin confirmed
BC08118 Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 100 cases_100 cores
BC08118 Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 100 cases_100 cores
BC08118 Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 100 cases_100 cores; ihc Anti-Actin confirmed
BR246a Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 12 cases_24 cores, replacing BR246
BR246a Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 12 cases_24 cores, replacing BR246
BR246a Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 12 cases_24 cores, replacing BR246; ihc Anti-Actin confirmed
BR1504 Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 75 cases_150 cores
BR1504 Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 75 cases_150 cores
BR1504 Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 75 cases_150 cores; ihc Anti-Actin confirmed
BR8018 Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 80 cases_80 cores, replacing BR808, BC08014
BR8018 Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 80 cases_80 cores, replacing BR808, BC08014; ihc Anti-Actin confirmed
BR802b Breast invasive ductal carcinoma with matched or unmatched adjacent normal breast tissue array, including TNM and pathology grade, 47cases_80cores, replacing BR802
BR802b Breast invasive ductal carcinoma with matched or unmatched adjacent normal breast tissue array, including TNM and pathology grade, 47cases_80cores, replacing BR802; ihc Anti-Actin confirmed
BR809 Breast invasive lobular carcinoma tissue array with adjacent normal tissue, 79 cases_80 cores
BR809 Breast invasive lobular carcinoma tissue array with adjacent normal tissue, 79 cases_80 cores; ihc Anti-Actin confirmed
BRN801 Breast normal adjacent tissue (NAT) and cancer tissue array, 80 cases_80 cores, replaced by BRN801a; ihc Anti-Actin confirmed
BRN801 Breast normal adjacent tissue and cancer tissue array, 80 cases_80 cores, replacing BN08013
BR1003 Breast pre-cancerous disease and cancer tissue array (100 cases_101 cores), with clinical stage and pathology grade data; ihc Anti-Actin confirmed
BR1003 Breast pre_cancerous disease and cancer tissue array (100 cases_101 cores), with clinical stage and pathology grade data
BR602 Breast tumor and normal tissue array, with TNM data, 25 cases_60 cores
BR2087 Breast tumor survey tissue array (1 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores
BR2087 Breast tumor survey tissue array (1 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed
BR20832 Breast tumor survey tissue array (1 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases_208 cores
BR20832 Breast tumor survey tissue array (1 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases_208 cores; ihc Anti-Actin confirmed
BR20816 Breast tumor survey tissue array (10 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores
BR20816 Breast tumor survey tissue array (10 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed
BR20817 Breast tumor survey tissue array (11 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores
BR20817 Breast tumor survey tissue array (11 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed
BR20818 Breast tumor survey tissue array (12 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores
BR20818 Breast tumor survey tissue array (12 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed
BR20819 Breast tumor survey tissue array (13 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores
BR20819 Breast tumor survey tissue array (13 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed
BR20820 Breast tumor survey tissue array (14 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores
BR20820 Breast tumor survey tissue array (14 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed
BR20821 Breast tumor survey tissue array (15 of 25), including TNM and pathology grade, 104 cases_208 cores
BR20821 Breast tumor survey tissue array (15 of 25), including TNM and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed
BR20822 Breast tumor survey tissue array (16 of 25), including TNM and pathology grade, 104 cases_208 cores
BR20822 Breast tumor survey tissue array (16 of 25), including TNM and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed
BR20823 Breast tumor survey tissue array (17 of 25), including TNM and pathology grade, 104 cases_208 cores
BR20823 Breast tumor survey tissue array (17 of 25), including TNM and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed
BR20824 Breast tumor survey tissue array (18 of 25), including TNM and pathology grade, 104 cases_208 cores
BR20824 Breast tumor survey tissue array (18 of 25), including TNM and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed
BR20825 Breast tumor survey tissue array (19 of 25), including TNM and pathology grade, 104 cases_208 cores
BR20825 Breast tumor survey tissue array (19 of 25), including TNM and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed
BR2088 Breast tumor survey tissue array (2 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores
BR2088 Breast tumor survey tissue array (2 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed
BR20833 Breast tumor survey tissue array (2 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases_208 cores
BR20833 Breast tumor survey tissue array (2 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases_208 cores; ihc Anti-Actin confirmed
BR20826 Breast tumor survey tissue array (20 of 25), including TNM and pathology grade, 104 cases_208 cores
BR20826 Breast tumor survey tissue array (20 of 25), including TNM and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed
BR20827 Breast tumor survey tissue array (21 of 25), including TNM and pathology grade, 104 cases_208 cores
BR20827 Breast tumor survey tissue array (21 of 25), including TNM and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed
BR20828 Breast tumor survey tissue array (22 of 25), including TNM and pathology grade, 104 cases_208 cores
BR20828 Breast tumor survey tissue array (22 of 25), including TNM and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed
BR20829 Breast tumor survey tissue array (23 of 25), including TNM and pathology grade, 104 cases_208 cores
BR20829 Breast tumor survey tissue array (23 of 25), including TNM and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed
BR20830 Breast tumor survey tissue array (24 of 25), including TNM and pathology grade, 104 cases_208 cores
BR20830 Breast tumor survey tissue array (24 of 25), including TNM and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed
BR20831 Breast tumor survey tissue array (25 of 25), including TNM and pathology grade, 104 cases_208 cores
BR20831 Breast tumor survey tissue array (25 of 25), including TNM and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed
BR2089 Breast tumor survey tissue array (3 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores
BR2089 Breast tumor survey tissue array (3 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed
BR20834 Breast tumor survey tissue array (3 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases_208 cores
BR20834 Breast tumor survey tissue array (3 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases_208 cores; ihc Anti-Actin confirmed
BR20810 Breast tumor survey tissue array (4 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores
BR20810 Breast tumor survey tissue array (4 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed
BR20835 Breast tumor survey tissue array (4 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases_208 cores
BR20835 Breast tumor survey tissue array (4 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases_208 cores; ihc Anti-Actin confirmed
BR20811 Breast tumor survey tissue array (5 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores
BR20811 Breast tumor survey tissue array (5 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed
BR20836 Breast tumor survey tissue array (5 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases_208 cores
BR20836 Breast tumor survey tissue array (5 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases_208 cores; ihc Anti-Actin confirmed
BR20812 Breast tumor survey tissue array (6 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores
BR20812 Breast tumor survey tissue array (6 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed
BR20813 Breast tumor survey tissue array (7 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores
BR20813 Breast tumor survey tissue array (7 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed
BR20814 Breast tumor survey tissue array (8 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores
BR20814 Breast tumor survey tissue array (8 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed
BR20815 Breast tumor survey tissue array (9 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores
BR20815 Breast tumor survey tissue array (9 of 25), including TNM, clinical stage and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed
BR1006 Breast tumor tissue array of varieties and normal adjacent tissue (NAT), 50 cases_100 cores
BR1006 Breast tumor tissue array of varieties and normal adjacent tissue (NAT), 50 cases_100 cores; ihc Anti-Actin confirmed
BR801 Breast tumor tissue array, with matched tumor and adjacent normal tissue, 40 cases_80 cores, replaced by BR804
BR801 Breast tumor tissue array, with matched tumor and adjacent normal tissue, 40 cases_80 cores, replaced by BR804; ihc Anti-Cytokeratin (High MW) confirmed
BR804 Breast tumor tissue array, with matched tumor and adjacent normal tissue, 40 cases_80 cores, replaced by BR804a; ihc Anti-Cytokeratin (Low-MW) confirmed
BR804 Breast tumor tissue array, with matched tumor and adjacent normal tissue, replacing BR801, 40 cases_80 cores
BR723 Breast various pathology developmental process tissue array, including TNM and pathology grade, 71 cases_72 cores
BR723 Breast various pathology developmental process tissue array, including TNM and pathology grade, 71 cases_72 cores; ihc Anti-Actin confirmed
BC01071 Carcinoma of stomach, liver and rectum tissue array, 45 cases _48 cores
BC01071 Carcinoma of stomach, liver and rectum tissue array, 45 cases _48 cores, replaced by BC01071a; ihc Anti-P53 confirmed
BC00116 Carcinoma with adjacent-tissue combined panel tissue array, 44 cases_48 cores; ihc Anti-Cytokeratin (CK) confirmed
BC00116 Carcinoma with adjacent_tissue combined panel tissue array, 44 cases_48 cores
CVD481 Cardiovascular disease tissue array, no overlapping with CVD231, 24 cases_48 cores
CVD481 Cardiovascular disease tissue array, no overlapping with CVD231, 24 cases_48 cores; ihc H&E, IHC anti-CD34
CVD231 Cardiovascular disease tissue array, non-overlapping with CVD481, 23 cases_23 cores; ihc H&E, IHC anti-CD34
CVD231 Cardiovascular disease tissue array, non_overlapping with CVD481, 23 cases_23 cores
BS36011 Cartilages sarcoma (Chondrosarcoma) tissue array, 25 cases_75 cores, replaced by OS803
BS36011 Cartilages sarcoma (Chondrosarcoma) tissue array, 25 cases_75 cores, replaced by OS803; ihc Anti-PCNA confirmed
CNS2081 Central nerve disease spectrum (central nerve tumor progression) tissue array, 104 cases_208 cores
CNS2081 Central nerve disease spectrum (central nerve tumor progression) tissue array, 104 cases_208 cores; ihc Anti-Actin confirmed
CR804 Cervical cancer and normal tissue array with TNM and grade, 40 cases_80 cores
CR804 Cervical cancer and normal tissue array with TNM and grade, 40 cases_80 cores; ihc Anti-Actin confirmed
CR501 Cervical cancer and normal tissue array with TNM and grade, 50 cases_50 cores
CR501 Cervical cancer and normal tissue array with TNM and grade, 50 cases_50 cores; ihc Anti-Actin confirmed
BC10025 Cervical cancer and normal tissue array, 54 cases_54 cores
BC10025 Cervical cancer and normal tissue array, 54 cases_54 cores; ihc Anti-Actin confirmed
CXC962 Cervical cancer and normal tissue array, non-overlapping with CXC961, 48 cases_96 cores; ihc H&E, IHC anti-Cytokeratin
CXC961 Cervical cancer and normal tissue array, non-overlapping with CXC962, 48 cases_96 cores; ihc H&E, IHC anti-Cytokeratin
CXC962 Cervical cancer and normal tissue array, non_overlapping with CXC961, 48 cases_96 cores
CXC961 Cervical cancer and normal tissue array, non_overlapping with CXC962, 48 cases_96 cores
CR208 Cervical cancer high density tissue array, with normal cervix tissue as control, 69 cases_208 cores, with grade and stage
CR208 Cervical cancer high density tissue array, with normal cervix tissue as control, 69 cases_208 cores, with grade and stage; ihc Anti-Actin confirmed
CXC1501 Cervical cancer mid-density tissue array, 75 cases_150 cores; ihc H&E, IHC anti-Cytokeratin
CXC1501 Cervical cancer mid_density tissue array, 75 cases_150 cores
CR2084 Cervical cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases_208 cores
CR2084 Cervical cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases_208 cores; ihc Anti-Actin confirmed
T103 Cervical cancer test tissue array, with normal tissue as control, including TNM and pathology grade, 6 cases_24 cores
T103 Cervical cancer test tissue array, with normal tissue as control, including TNM and pathology grade, 6 cases_24 cores; ihc Anti-Actin confirmed
CR245 Cervical cancer tissue array with matched adjacent cervical tissue, including TNM, clinical stage and pathology grade, 12 cases_24 cores; ihc Anti-Actin confirmed
CR481 Cervical cancer tissue array with normal adjacent tissues, 24 cases_48 cores, with grade and stage data
CR481 Cervical cancer tissue array with normal adjacent tissues, 24 cases_48 cores, with grade and stage data; ihc Anti-Actin confirmed
CR811 Cervical cancer tissue array with normal tissues from autopsy, 40 cases_80 cores, with grade and TNM data
CR811 Cervical cancer tissue array with normal tissues from autopsy, 40 cases_80 cores, with grade and TNM data; ihc Anti-Actin confirmed
CXC241 Cervical cancer tissue array, 12 cases_24 cores
CXC241 Cervical cancer tissue array, 12 cases_24 cores; ihc H&E, IHC anti-Cytokeratin
T104 Cervical cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases_24 cores; ihc Anti-Actin confirmed
CR1501 Cervical cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases_150 cores; ihc Anti-Actin confirmed
CR802 Cervical cancer tissue array, matched or unmatched tumor and adjacent normal tissue, 74 cases_80 cores
CR802 Cervical cancer tissue array, matched or unmatched tumor and adjacent normal tissue, 74 cases_80 cores; ihc Anti-Cytokeratin (CK) confirmed
CR601 Cervical carcinoma tissue array with cervical disease spectrum (normal, inflammation, CIN, malignant I-III), 59 cases_60 cores, replaced by CR602; ihc Anti-Cytokeratin (CK)
CR601 Cervical carcinoma tissue array with cervical disease spectrum (normal, inflammation, CIN, malignant I_III), 59 cases_60 cores, replaced by CR602
CR701 Cervical carcinoma, adjacent tissue and adjacent normal tissue array, including TNM and pathology grade, 70 cases_70 cores
CR701 Cervical carcinoma, adjacent tissue and adjacent normal tissue array, including TNM and pathology grade, 70 cases_70 cores; ihc Anti-Actin confirmed
CIN481 Cervical intraepithelial neoplasia tissue array with cervical disease spectrum, 48 cases_48 cores
CIN481 Cervical intraepithelial neoplasia tissue array with cervical disease spectrum, 48 cases_48 cores; ihc H&E, IHC anti-Cytokeratin
CR485 Cervix cancer and adjacent normal tissue array, including TNM and pathology grade, 48 cases_48 cores
CR485 Cervix cancer and adjacent normal tissue array, including TNM and pathology grade, 48 cases_48 cores; ihc Anti-Actin confirmed